IIPLA Newsroom Access

Sign in with Google to continue in IP News.

Google SSO gives you the quickest path into the IIPLA newsroom, your reading access, and member-level continuity across articles. The full login page is still available if you prefer another option.

IIPLA News
Wednesday, April 29, 2026

Ukrainian Legal Experts Challenge Tax Authority’s Classification of Transport Leasing Payments as Royalties

Efforts by Ukraine’s Bureau of Economic Security to tax vehicle leasing as royalties spark legal debate and industry concerns

IIPLA News Deskanonymous access0 articles left this week
The legal nature of leasing: lawyer explains why transport payments cannot be royalties
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

Ukrainian legal professionals are raising alarms over the Bureau of Economic Security’s attempts to classify leasing payments for vehicles, including aircraft, as royalties subject to additional taxation. Experts argue that such payments do not involve the transfer of intellectual property rights and warn that the mov…
Related Coverage

Continue in the newsroom

Back to newsroom
PatentsUSA

Moderna to Pay Up to $2.25B to Settle COVID-19 Vaccine Patent Lawsuit

Biotechnology company Moderna has agreed to pay up to $2.25 billion to settle patent litigation over technology used in its COVID-19 vaccine, resolving a dispute with Arbutus Biopharma and Genevant Sciences. The lawsuits alleged that Moderna’s vaccine relied on patented lipid nanoparticle delivery systems, a technolog…

Wednesday, April 29, 2026
PatentsUSA

Supreme Court Issues Key Rulings and Hears New Cases on Intellectual Property in 2024

The U.S. Supreme Court concluded its 2023-24 term with significant decisions impacting intellectual property law, including a unanimous ruling on the Lanham Act’s name clause and a split decision on the timing of copyright damages. As the 2024-25 term begins, the Court has agreed to hear additional IP cases while decl…

Wednesday, April 29, 2026
PatentsUSA

Federal Circuit Confirms Generic Drugmakers Can Deduct Hatch-Waxman Litigation Costs

In a landmark decision, the Federal Circuit has ruled that generic pharmaceutical companies may deduct legal expenses incurred in defending Hatch-Waxman patent litigation as ordinary and necessary business expenses. The ruling, which affirms a lower court's decision in favor of Actavis Laboratories FL, Inc., clarifies…

Wednesday, April 29, 2026
PatentsUSA

Texas Patent Litigation Sees Shifts Amid Judicial Reassignment and Case Filings Trends

Patent litigation in Texas experienced notable changes in 2022 following a judicial order that altered case assignment in the Western District. While filings in the Western District of Texas (WDTX) declined after the order, the drop was less severe than anticipated, and Judge Alan Albright continued to preside over a…

Wednesday, April 29, 2026